Delivery Order SPE2DR25D2006-SPE2DR26F59ZF
Award Date 4/23/26
Potential Completion Date 4/24/26
Potential Value $54K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $26,118.05 delivery order to AmerisourceBergen Drug Corp on April 3, 2026, for 36,000 unit capsules of Creon DR 100s, with ultimate completion by April 6, 2026. The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued a $15,728.80 delivery order to Amerisourcebergen Drug Corp on April 10, 2026, for 36,000 unit capsules of Creon DR 100s, with an ultimate completion date of April 13, 2026. Place of performance is Conshohocken, PA. The order is issued under firm fixed-price terms with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the Defense Logistics Agency's...
- The Defense Logistics Agency issued a $20,023.90 delivery order to Amerisourcebergen Drug Corp on April 16, 2026, for 36,000 unit capsules of Creon DR 100s, with an ultimate completion date of April 17, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor supplying the Defense Logistics Agency under its Troop Support Medical indefinite...
- The Defense Logistics Agency issued a $2,555.82 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, for 36,000 unit capsules of Creon DR 100s with an ultimate completion date of April 21, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier serving Department of Defense and federal healthcare systems.
- The Defense Logistics Agency issued a $20,493.32 delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for 36,000 unit capsules of Creon DR 100s. The order is placed against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which supplies pharmaceutical products and medical commodities to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order has a...
- The Defense Logistics Agency issued a $18,684.70 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for 36,000 unit capsules of Creon DR 100s, with ultimate completion on March 13, 2026. The order is placed under Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued a $21,284.26 delivery order to Amerisourcebergen Drug Corp on March 31, 2026, for 36,000 unit capsules of Creon DR 100s. The order is placed under the company's indefinite delivery contract with DLA Troop Support Medical, a $999,999,999 vehicle running through December 2026 that supplies pharmaceutical products and medical commodities globally to military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing with...
- The Defense Logistics Agency issued a $9,501.58 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for 24,000 unit capsules of Creon DR 100s, with ultimate completion on April 21, 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor under DLA Troop Support Medical indefinite delivery contracts supporting military...
- The Defense Logistics Agency issued a $12,451.56 delivery order to Amerisourcebergen Drug Corp on April 10, 2026, for 36,000 unit capsules of Creon DR 100s, with ultimate completion by April 13, 2026. The order is issued under an Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026. This prime vendor vehicle enables supply of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place...
- The Defense Logistics Agency issued a $5,132.44 delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for 36,000 unit capsules of Creon DR 100s, with ultimate completion by March 17, 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside. AmerisourceBergen Drug Corp operates under a parent indefinite delivery contract with DLA Troop Support Medical valued at $999,999,999 through December 2026, which serves as the comprehensive global...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F59ZFDelivery Order
The Defense Logistics Agency issued a $53,864.53 delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for 36,000 unit capsules of Creon DR 100s pharmaceutical product, with ultimate completion on April 24, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and holds a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for military healthcare supply.
Generated 7/22/26, 10:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.9k | 4/22/26 |